rtki cpd has been researched along with Hypertrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, JW; Brown, JH; Howes, AL; Miyamoto, S; Woodcock, EA | 1 |
| Baatar, D; Pai, R; Pavelka, M; Soreghan, B; Szabo, IL; Tarnawski, AS | 1 |
2 other study(ies) available for rtki cpd and Hypertrophy
| Article | Year |
|---|---|
Galphaq expression activates EGFR and induces Akt mediated cardiomyocyte survival: dissociation from Galphaq mediated hypertrophy.
Topics: Animals; Apoptosis; Cell Survival; Cells, Cultured; Enzyme Inhibitors; ErbB Receptors; GTP-Binding Protein alpha Subunits, Gq-G11; Heart Ventricles; Hypertrophy; Myocardium; Myocytes, Cardiac; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Rats; Transcriptional Activation; Tyrphostins | 2006 |
Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy.
Topics: Animals; Cell Line; Colonic Neoplasms; Dinoprostone; Enzyme Inhibitors; ErbB Receptors; Gastric Mucosa; Genes, src; Humans; Hypertrophy; MAP Kinase Signaling System; Matrix Metalloproteinases; Mitogen-Activated Protein Kinase 1; Phosphorylation; Quinazolines; Rats; Rats, Sprague-Dawley; Transcriptional Activation; Tyrphostins | 2002 |